NCT03030378 2026-03-19Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid TumorsNational Cancer Institute (NCI)Phase 1 Active not recruiting36 enrolled
NCT01468896 2026-03-18Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1/2 Active not recruiting23 enrolled 11 charts